Study to Evaluate the Efficacy of Uproleselan in Combination With Chemotherapy in Chinese Patients With R/R AML

Clinical trial NCT05054543 · TERMINATED

Trial details

NCT number: NCT05054543
Sponsor: Apollomics Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Relapsed/Refractory AML

Start date: 2021-11-17
Primary completion: 2024-08-22
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.